The World Health Organization (WHO) on Tuesday said “extra explanations” are required from Bharat Biotech in regards to its Covid-19 immunization ‘Covaxin’ for a last “hazard advantage evaluation” prior to suggesting the antibody for crisis use. “The Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an autonomous warning gathering […]